Evaluation of human serum albumin as a substitute of foetal bovine serum for cell culture

Calafiore, 2004, Grafs of microencapsulated pancreatic islet cells for the therapy of diabetes mellitus in non-immunosuppressed animals, Biotechnol. Appl. Biochem., 39, 159, 10.1042/BA20030151 Chang, 1964, Semipermeable microcapsules, Science, 146, 524, 10.1126/science.146.3643.524 Chang, 2004, Artificial cells for cell and organ replacements, Artif. Organs, 28, 265, 10.1111/j.1525-1594.2004.47343.x Cirone, 2004, Combined immunotherapy and antiangiogenic therapy of cancer with microencapsulated cells, Hum. Gen. Ther., 15, 945, 10.1089/hum.2004.15.945 Committee For Proprietary Medical Products, 2003. Note for guidance on the use of bovine serum in the manufacture of human biological medical products. The European Agency for the Evaluation of Medical Produtcs, viewed 15 July 2005, <http://www.emea.eu.int/pdfs/human/bwp/179302en.pdf>. Dornish, 2001, Standards and guidelines for biopolymers in tissue-engineered medical products: ASTM alginate and chitosan standard guides. American Society for Testing and Materials, Ann. NY Acad. Sci., 944, 388, 10.1111/j.1749-6632.2001.tb03850.x Ha, 2003, Human serum albumin and its structural variants mediate cholesterol efflux from cultured endothelial cells, Biochim. Biophys. Acta, 1640, 119, 10.1016/S0167-4889(03)00027-2 Hortelano, 1999, Persistent delivery of factor IX in mice: gene therapy for hemophilia using implantable microcapsules, Hum. Gen. Ther., 10, 1281, 10.1089/10430349950017969 Joly, 1997, Survival, proliferation and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver, Transplantation, 63, 795, 10.1097/00007890-199703270-00002 Levy, 1996, Coating alginate beads with cross-linked biopolymers: a novel method based on a transacylation reaction, J. Microencapsul., 13, 169, 10.3109/02652049609052905 Orive, 2002, Encapsulated cell technology: from research to market, Trends Biotechnol., 20, 382, 10.1016/S0167-7799(02)02037-1 Orive, 2003, Cell microencapsulation technology for biomedical purposes: novel insights and challenges, Trends Pharmacol. Sci., 24, 207, 10.1016/S0165-6147(03)00073-7 Orive, 2003, Cell encapsulation: promise and progress, Nat. Med., 9, 104, 10.1038/nm0103-104 Orive, 2004, History, challenges and perspectives of cell microencapsulation, Trends Biotechnol., 22, 87, 10.1016/j.tibtech.2003.11.004 Schneider, 2003, Beneficial effects of human serum albumin on stability and functionality of alginate microcapsules fabricated in different ways, J. Microencapsul., 20, 627, 10.1080/0265204031000140796 Shinya, 1999, In vivo delivery of therapeutic proteins by genetically-modified cells: comparison of organoids and human serum albumin alginate-coated beads, Biomed. Pharmacother., 53, 471, 10.1016/S0753-3322(00)88106-8 Uludag, 1990, Colorimetric assay for cellular activity in microcapsules, Biomaterials, 11, 708, 10.1016/0142-9612(90)90032-L